DFDA

Gabapentin (Off-label)

Treatment for Alcohol Use Disorders

Typical Dosage: 900-1800mg daily (titrated)

Effectiveness
30%
Safety Score
68%
Clinical Trials
40
Participants
6K

Comparative Safety Scale(Higher is safer)

Cyanide☠ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
68
DangerousModerateSafe
Treatment Details
Dosage Range
900-1800mg daily (titrated)
Time to Effect
1-3 weeks
Treatment Duration
3-12 months
Evidence Quality
MODERATE
Number Needed to Treat (NNT)
12(Treat 12 patients to see 1 additional successful outcome)
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$400
Side Effect Mgmt:$100
Total Annual:$1,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
ICER
$50,000/QALY
QALYs Gained
0.1
Outcome-Based Costs
Cost per Responder
$3,333
Cost per Remission
$6,667
Prescription Access Economics
Risk Assessment
Misuse Risk
LOW
Missed Diagnosis Risk
LOW
Gabapentin (Off-label) Outcomes

for Alcohol Use Disorders

Efficacy Outcomes
Overall Effectiveness
+30%
Response Rate
+30%
Remission Rate
+15%
Common Side Effects
Dizziness
+15%
Somnolence
+12%
Peripheral edema
+7%

Sources:

researchgate.net
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov